If treatment not possible in Pakistan, govt won't stop Nawaz going abroad: Tareen

PTI senior leader says Bilawal-Nawaz meeting was purely personal, not political

News Desk March 11, 2019
Nawaz Sharif (left and Jehangir Tareen. PHOTO: FILE

Pakistan Tehreek-e-Insaf (PTI) senior leader Jehangir Tareen on Monday said that if former premier Nawaz Sharif's illness can't be properly treated in the country then the government would not stop him from going overseas, Express News reported.

"If Nawaz's treatment can only be done in London, then the government will look into it," Tareen said while speaking at an event in Lahore.

In the same breath. he suggested that the Pakistan Muslim League-Nawaz (PML-N) top leader should get his treatment in the country. "An entire mobile cardiac care unit is now at his disposal."

Last year on December 24 an accountability court convicted Nawaz in Al-Azizia reference and sentenced him to seven-year rigourous imprisonment while also imposing on him a hefty fine.

PM Imran wishes 'good health' to ailing Nawaz Sharif

When asked about the three-time premier's bail application being accepted, the PTI leader said that the decision is not up to the government and would be decided by courts.

Talking about today's meeting between Nawaz and Pakistan Peoples Party (PPP) Chairman Bilawal Bhutto Zardari, Tareen said: "Bilawal made it clear that the meeting was purely on a personal level to inquire about his health and not political."

Nawaz, who is currently incarcerated at the Lahore's Kot Lakhpat jail and has been suffering from cardiac issues.


Carrie | 5 years ago | Reply Quality articles is the key to interest the people to visit the web site, that's what this site is providing.카지노사이트
Sameer | 5 years ago | Reply Shame on Tareen. Better to stay away and shut up. This is not your or governments call. Those who let him leave will destroy any hope the country has for progress.
Replying to X

Comments are moderated and generally will be posted if they are on-topic and not abusive.

For more information, please see our Comments FAQ